Zkusit zdarma
Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

YMAB
Cena:
 
 
Valuace
70
Růst
53
Zdraví
75
preloader

Finanční výsledky Y-mAbs Therapeutics, Inc. (YMAB)

Měna: USD

Ukazatel20242023202220212020
Diluted EPS-0.67-0.49-2.19-1.28-2.97
Gross Profit72.7M73.5M57.8M32.6M-
Net Income Attributable to Common Shareholders-29.7M-21.4M-95.6M-55.3M-119.3M
Operating Profit-31.2M-25.7M-94.8M-115.4M-119.9M
Total Revenues87.7M84.8M65.3M34.9M20.8M